Mark Kay

Mark Kay is a Scientific Advisor at Carmine Therapeutics. Mark was previously a Voyager Therapeutics and has also worked with Stanford University School of Medicine and the University of Washington School of Medicine. Mark has been an Associate Professor at both the University of Washington and Stanford University.

After receiving a BS in physical sciences from Michigan State University, Mark Kay pursued an MD and PhD in developmental genetics and medicine at Case Western Reserve University School of Medicine. Mark is now eligible for pediatrics and medical genetics, and their field is Pediatrics and Medical Genetics.